An Overview of Diabetic Nephropathy

Author:

Nesbitt Kenyetta N.1

Affiliation:

1. 2915 WaterchaseWay #307,Wyoming, MI 49509

Abstract

Diabetic nephropathy is a complication of type 1 and type diabetes mellitus and the leading cause of end-stage renal disease in the United States. The health care system spends billions of dollars every year to treat end-stage renal disease patients. Health care providers must address diabetic nephropathy. The American Diabetes Association set forth recommendations for early detection to slow the progression of renal disease and treatment guidelines for patients with diabetes along with hypertension and diabetic nephropathy. Routine screening and treatment are the key to ending the trend of patients with diabetic nephropathy progressing to end-stage renal disease. Glycemic and blood pressure control is important for managing diabetic nephropathy. Angiotensinconverting enzyme inhibitors and angiotensin receptor blockers have become drugs of choice for treating diabetic nephropathy, based on clinical studies showing they slow the progression of renal disease. Whether protein restrictions are necessary in patients with diabetic nephropathy is being debated.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3